256 New York — New York, New York

256 New York is a clinical research site located in New York, New York, United States 10065.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

256 New York has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Chronic Hepatitis D Infection.

Sponsors: Mirum Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 256 New York?

256 New York has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 256 New York conducted?

256 New York has 1 clinical trials on record, with 1 currently active. Their work covers Chronic Hepatitis D Infection.

Is 256 New York accredited by Crixeo Health?

256 New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 256 New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.